David Epstein, Seagen CEO
Seagen rolls out data for Adcetris combination to treat Hodgkin lymphoma
Seagen has long held on to Adcetris as one of its top-selling and expanded products, and the latest data for the drug, used in combination …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
